Chemical pleurodesis–a review of mechanisms involved in pleural space obliteration

M Mierzejewski, P Korczynski, R Krenke… - Respiratory Research, 2019 - Springer
Chemical pleurodesis is a therapeutic procedure applied to create the symphysis between
the parietal and visceral pleura by intrapleural administration of various chemical agents (eg …

Notch signaling in lung diseases: focus on Notch1 and Notch3

D Zong, R Ouyang, J Li, Y Chen… - … advances in respiratory …, 2016 - journals.sagepub.com
Notch signaling is an evolutionarily conserved cell–cell communication mechanism that
plays a key role in lung homeostasis, injury and repair. The loss of regulation of Notch …

[HTML][HTML] Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer

YY Wu, YL Hsu, YC Huang, YC Su, KL Wu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Lung cancer is associated with a high mortality rate and often complicated with
malignant pleural effusion (MPE), which has a very poor clinical outcome with a short life …

The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET

Y Kong, DB Allison, Q Zhang, D He, Y Li, F Mao… - Science …, 2022 - science.org
Increased abundance of polo-like kinase 1 (PLK1) is observed in various tumor types,
particularly in lung adenocarcinoma (LUAD). Here, we found that PLK1 accelerated the …

Genomics and epigenetics of malignant mesothelioma

AP Sage, VD Martinez, BC Minatel, ME Pewarchuk… - High-throughput, 2018 - mdpi.com
Malignant mesothelioma is an aggressive and lethal asbestos-related disease. Diagnosis of
malignant mesothelioma is particularly challenging and is further complicated by the lack of …

A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study

H Deng, J Deng, X Lin, W Guan, Z Lin, Y Qiu… - Clinical Drug …, 2023 - Springer
Abstract Background and Objective Checkpoint inhibitor-related pneumonitis (CIP) is one of
the most common serious and fatal adverse events associated with immune checkpoint …

[HTML][HTML] Unraveling the role of STK11/LKB1 in non-small cell lung cancer

V Sumbly, I Landry - Cureus, 2022 - ncbi.nlm.nih.gov
There are two major groups of lung cancer: non-small cell lung cancer (NSCLC) and small
cell lung cancer (SCLC). NSCLCs can be further separated into three different categories …

TLD1433-Mediated photodynamic therapy with an optical surface applicator in the treatment of lung cancer cells in vitro

S Chamberlain, HD Cole, J Roque III, D Bellnier… - Pharmaceuticals, 2020 - mdpi.com
Intra-operative photodynamic therapy (IO-PDT) in combination with surgery for the treatment
of non-small cell lung cancer and malignant pleural mesothelioma has shown promise in …

Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer

Z Yang, Z Song, Z Chen, Z Guo, H Jin, C Ding… - … of Pharmaceutical and …, 2020 - Elsevier
Malignant pleural effusion (MPE) is an important hallmark for late-stage lung cancer with
metastasis. Current clinical diagnosis methods require tedious work to distinguish MPE from …

Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1

A Lukic, CJE Wahlund, C Gómez, D Brodin… - Cancer letters, 2019 - Elsevier
Tumor-derived exosomes can modulate the cancer microenvironment and induce metastatic
spread. Exosomes may carry enzymes for leukotriene (LT) biosynthesis, but the role of …